Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes

Details for Australian Patent Application No. 2007218053 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors Weber, Ann E.; Caldwell, Charles G.; Cox, Jason M.; Biftu, Tesfaye; Chen, Ping; Feng, Danqing; Qian, Xiaoxia

Agent Spruson & Ferguson

Pub. Number AU-B-2007218053

PCT Pub. Number WO2007/097931

Priority 60/773,809 15.02.06 US

Filing date 9 February 2007

Wipo publication date 30 August 2007

Acceptance publication date 27 May 2010

International Classifications

C07D 405/04 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

Event Publications

14 August 2008 PCT application entered the National Phase

  PCT publication WO2007/097931 Priority application(s): WO2007/097931

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

27 May 2010 Application Accepted

  Published as AU-B-2007218053

23 September 2010 Standard Patent Sealed

11 October 2012 Alteration of Name

  The name of the patentee has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007218059-Pyrrolidine derivatives as ERK inhibitors

2007218051-Compounds and methods for treatment of stroke